AI Article Synopsis
- The study compared the effectiveness of myocardial perfusion (MP) and wall motion (WM) analysis using real-time myocardial contrast echocardiography (RTMCE) with two contrast agents (Optison and Definity) in detecting coronary artery disease following regadenoson stress.
- A total of 150 patients underwent RTMCE after receiving regadenoson, with sensitivity, specificity, and accuracy for both agents evaluated against quantitative angiography results.
- Results indicated that while both contrast agents demonstrated similar overall efficacy, the addition of MP analysis enhanced the accuracy of Definity, suggesting that MP may improve detection depending on the rate-pressure product achieved.
Article Abstract
Background: The aim of this study was to compare the efficacy of myocardial perfusion (MP) and wall motion (WM) analysis obtained with real-time myocardial contrast echocardiography (RTMCE) and two widely used contrast agents in detecting coronary artery disease after injection of the vasodilator regadenoson.
Methods: One hundred fifty patients were studied at two academic centers using regadenoson (400-μg intravenous bolus) vasodilator stress RTMCE (7.5% Optison infusion [n = 50] or 1.5% Definity infusion [n = 100]). Both MP and WM with RTMCE were analyzed at rest and after regadenoson bolus. Comparisons of WM and MP sensitivity, specificity, and accuracy were made. Quantitative angiography was performed in all patients within 1 month of the regadenoson stress study (>50% and >70% diameter stenosis was considered significant). Reviewers were blinded to all clinical and quantitative angiographic data.
Results: Rate-pressure product after regadenoson was higher in Optison than Definity patients (P = .004). Using a 50% diameter stenosis on quantitative angiography as a reference standard, overall sensitivity, specificity, and accuracy for combined WM and MP analysis were not different for both agents (Optison, 77%, 64%, and 73%; Definity, 80%, 74%, and 78%; P = NS). The sensitivity, specificity, and accuracy of WM analysis alone for Optison were 68%, 71%, and 69% compared with 60%, 72%, and 66% for Definity (P = NS). Adding MP analysis improved the sensitivity and accuracy of Definity for detecting both >50% and >70% stenoses (P < .001 vs WM), while MP analysis did not improve the sensitivity of Optison for detecting either >50 or >70% stenoses.
Conclusions: RTMCE during regadenoson stress using either Optison or Definity is a rapid and effective method for the detection of coronary artery disease. The ability of MP imaging to improve WM accuracy may depend on the rate-pressure product achieved.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.echo.2015.08.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Usefulness of dynamic perfusion SPECT with quantitative assessment of myocardial perfusion reserve for the detection of myocardial ischaemia in patients with presumed new left bundle branch block.
Eur Heart J Imaging Methods Pract
July 2024
Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Univ, UNICAEN UR 4650 PSIR, Avenue Cote de Nacre, 14000 Caen, France.
Article Synopsis
- The study aimed to assess how well dynamic SPECT with quantitative analysis of myocardial blood flow (MBF) and myocardial flow reserve (MFR) can detect coronary artery disease (CAD) in patients with new left bundle branch block (LBBB).
- The evaluation involved 174 patients with LBBB, finding SPECT abnormalities in only a small percentage, and highlighting a correlation between reduced MFR and fixed defects, although only a few patients had significant CAD after further examination.
- The conclusion suggests that routine screening for CAD in patients with presumed new LBBB may not be necessary, given the low incidence of actual CAD found.
Diagnostic Accuracy of Dynamic Stress Myocardial CT Perfusion Compared with Invasive Physiology in Patients with Stents: The Advantage 2 Study.
Radiology
December 2024
From the Centro Cardiologico Monzino, IRCCS, Via C. Belgioioso 173, Milan, Italy (D.A., S.M., D.T., E.C., G.L., S. Galli, G.M., L.G., G.T., S.T., S. Gili, P.M., P.O., V.M., D.M., M.S., C.G., E.M., A.B., M.E.M., A.A., A F., G.P., A.L.B.); Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy (D.A.); IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan, Italy (E.C., G.M., L.G., V.M., D.M., M.S., E.G., P.P., E.M., A.L.B.); Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium (J.S., M.B., E.G., P.P., K.S., T.M., C.C.); Department of Medicine, Division of Cardiology, Showa University School of Medicine, Tokyo, Japan (K.S., T.M.); Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy (G.P.); and Department of Radiology, Azienda Ospedaliera di Padova, Padua, Italy (L.Z.).
Background The detection of in-stent restenosis (ISR) with coronary CT angiography (CCTA) is challenging, but CT perfusion (CTP) has demonstrated improved diagnostic accuracy over CCTA in patients with stents. However, there are limited data on the performance of dynamic CTP, which allows noninvasive adjudication of regional myocardial blood flow. Purpose To compare the diagnostic performance of regadenoson-stress dynamic CTP with that of CCTA, using fractional flow reserve (FFR) and the index of microvascular resistance (IMR) as reference standards for epicardial coronary circulation and coronary microcirculation, respectively.
View Article and Find Full Text PDFREGADENOSON MYOCARDIAL PERFUSION SCINTIGRAPHY: A SINGLE CENTRE EXPERIENCE.
J Ayub Med Coll Abbottabad
December 2024
Nuclear Medical Centre, Armed Forces Institute of Pathology, Rawalpindi-Pakistan.
Article Synopsis
- - Regadenoson is a selective A2A adenosine receptor agonist used for heart stress testing, and this study evaluates its safety for myocardial perfusion scans.
- - The study included 63 adult patients, primarily male with an average age of about 57, and looked at their health data and any adverse reactions after using Regadenoson during the testing process.
- - Results showed minor blood pressure drops that stabilized after an hour, with few non-serious side effects like shortness of breath and headaches, but no major health complications arose.
8-Aminopurines: A Promising New Direction for Purine-Based Therapeutics.
Hypertension
December 2024
Department of Pharmacology and Chemical Biology (E.K.J., S.P.T., Y.C., L.A.B.), University of Pittsburgh School of Medicine, Pittsburgh, PA.
Research in purinergic pharmacology has yielded major advances in cardiovascular therapeutics such as adenosine for terminating atrioventricular reentrant tachycardia, regadenoson for pharmacological ischemic stress testing, and selective P2Y receptor antagonists for prevention of stroke and myocardial infarction. Mechanistically, these FDA-approved purine-based therapeutics activate or antagonize receptors having endogenous ligands containing the purine nucleobase adenine. Recent discoveries suggest a novel direction for purine-based therapeutics.
View Article and Find Full Text PDFThe prognostic utility of heart rate and blood pressure response to regadenoson stress.
J Nucl Cardiol
October 2024
Division of Cardiology, Cook County Health, Chicago, IL, USA; Division of Cardiology, Rush University Medical Center, Chicago, IL, USA. Electronic address:
Background: Although heart rate response (HRR) to regadenoson stress has been shown to be a strong predictor of outcome, it has not been investigated in a large all-comers cohort. The prognostic utility of systolic blood pressure response (SBPR) has not been investigated in comparison with HRR.
Methods And Results: In a retrospective cohort of 10,227 patients undergoing regadenoson stress single-photon emission computed tomography myocardial perfusion imaging (MPI), HRR, and SBPR were calculated as 100×(peak hyperemia value-baseline value)/baseline value.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!